title: Therapeutic application of melatonin in mild cognitive impairment.
abstract: Mild cognitive impairment (MCI) is an etiologically heterogeneous syndrome defined by cognitive impairment in advance of dementia. We previously reported in a retrospective analysis that daily 3 - 9 mg of a fast-release melatonin preparation given p. o. at bedtime for up to 3 years significantly improved cognitive and emotional performance and daily sleep/wake cycle in MCI patients. In a follow up of that study we now report data from another series of 96 MCI outpatients, 61 of who had received daily 3 - 24 mg of a fast-release melatonin preparation p. o. at bedtime for 15 to 60 months. Melatonin was given in addition to the standard medication prescribed by the attending psychiatrist. Patients treated with melatonin exhibited significantly better performance in Mini-Mental State Examination and the cognitive subscale of the Alzheimer's disease Assessment Scale. After application of a neuropsychological battery comprising a Mattis´ test, Digit-symbol test, Trail A and B tasks and the Rey´s verbal test, better performance was found in melatonin-treated patients for every parameter tested. Abnormally high Beck Depression Inventory scores decreased in melatonin-treated patients, concomitantly with the improvement in the quality of sleep and wakefulness. The comparison of the medication profile in both groups of MCI patients indicated that 9.8% in the melatonin group received benzodiazepines vs. 62.8% in the non-melatonin group. The results further support that melatonin can be a useful add-on drug for treating MCI in a clinic environment.
authors: Departamento de Docencia e Investigación, Facultad de Ciencias Médicas, Pontificia Universidad Católica Argentina Buenos Aires, Argentina.
authors: Daniel P
authors: DP
authors: Cardinali
authors: Daniel E
authors: DE
authors: Vigo
authors: Natividad
authors: N
authors: Olivar
authors: María F
authors: MF
authors: Vidal
authors: Analía M
authors: AM
authors: Furio
authors: Luis I
authors: LI
authors: Brusco
keywords: Alzheimer´s disease; Mild cognitive impairment; benzodiazepines; melatonin; neuropsychological tests; retrospective study
references: Chronobiol Int. 2000 May;17(3):419-32
references: 10841214
references: Psychopharmacology (Berl). 1990;100(2):222-6
references: 2305009
references: J Pineal Res. 2003 Sep;35(2):125-30
references: 12887656
references: Arch Intern Med. 1999 Nov 8;159(20):2456-60
references: 10665894
references: J Neural Transm (Vienna). 2012 Oct;119(10):1233-9
references: 22488446
references: J Pineal Res. 2011 May;50(4):381-8
references: 21480979
references: Brain Cogn. 2006 Mar;60(2):146-55
references: 16446021
references: Neurosci Biobehav Rev. 1996 Autumn;20(3):403-12
references: 8880732
references: BMJ. 2012 Jan 05;344:d7622
references: 22223828
references: Life Sci. 2004 Aug 27;75(15):1843-56
references: 15302228
references: Lancet. 2009 Feb 7;373(9662):482-91
references: 19054552
references: Ann Neurol. 1999 Mar;45(3):358-68
references: 10072051
references: J Pineal Res. 2010 Apr;48(3):282-289
references: 20210854
references: J Nippon Med Sch. 2003 Aug;70(4):334-41
references: 12928714
references: BMJ. 2006 Feb 18;332(7538):385-93
references: 16473858
references: Sleep Med Rev. 2005 Feb;9(1):41-50
references: 15649737
references: Arch Neurol. 2009 Sep;66(9):1151-7
references: 19752306
references: Lancet Neurol. 2004 Apr;3(4):246-8
references: 15039037
references: Eur Neuropsychopharmacol. 1997 May;7(2):157-60
references: 9169303
references: JAMA. 2008 Jun 11;299(22):2642-55
references: 18544724
references: J Clin Endocrinol Metab. 1992 Jan;74(1):108-17
references: 1727807
references: Arch Neurol. 2004 Jan;61(1):59-66
references: 14732621
references: Arch Neurol. 1999 Mar;56(3):303-8
references: 10190820
references: J Neural Transm Suppl. 1998;53:127-40
references: 9700651
references: J Geriatr Psychiatry Neurol. 2007 Jun;20(2):67-75
references: 17548775
references: Neurobiol Aging. 1995 May-Jun;16(3):271-8; discussion 278-84
references: 7566337
references: Int Clin Psychopharmacol. 2011 Jan;26(1):48-53
references: 20861739
references: J Clin Endocrinol Metab. 2003 Dec;88(12):5898-906
references: 14671188
references: Sleep. 2003 Nov 1;26(7):893-901
references: 14655926
references: Int Psychogeriatr. 2004 Mar;16(1):51-60
references: 15190996
references: Percept Mot Skills. 1998 Aug;87(1):331-9
references: 9760668
references: Annu Rev Med. 2006;57:499-511
references: 16409163
references: Sleep Med. 2007 Sep;8(6):623-36
references: 17383938
references: J Sleep Res. 2009 Mar;18(1):129-35
references: 19250179
references: Ann Neurol. 2011 Nov;70(5):722-32
references: 22162057
references: J Neural Transm (Vienna). 2000;107(2):203-31
references: 10847561
references: J Pineal Res. 2012 Mar;52(2):167-202
references: 22107053
references: Neuroendocrinology. 2011;93(3):133-42
references: 21358175
references: Brain Res. 2005 Mar 10;1037(1-2):209-13
references: 15777772
references: Cell Mol Neurobiol. 2002 Dec;22(5-6):699-709
references: 12585689
references: Geriatr Gerontol Int. 2009 Sep;9(3):220-34
references: 19702931
references: Neurology. 2007 Dec 11;69(24 Suppl 3):S3-9
references: 18071156
references: Arch Gerontol Geriatr. 1999 Mar-Apr;28(2):85-98
references: 15374088
references: Neurotox Res. 2013 Apr;23(3):267-300
references: 22739839
references: J Pineal Res. 2012 May;52(4):365-75
references: 21951153
references: J Pineal Res. 2007 Nov;43(4):404-9
references: 17910609
references: J Neurol Sci. 2011 Aug 15;307(1-2):9-14
references: 21570695
references: J Pineal Res. 1998 Oct;25(3):177-83
references: 9745987
references: Neurology. 1988 Nov;38(11):1688-93
references: 3054625
references: J Pineal Res. 2005 Jan;38(1):10-6
references: 15617532
references: Lancet. 2012 Mar 24;379(9821):1129-41
references: 22265700
references: J Pineal Res. 2006 Nov;41(4):313-23
references: 17014688
references: Expert Opin Pharmacother. 2012 Jan;13(1):9-16
references: 22107732
references: Int Psychogeriatr. 2009 Aug;21(4):654-66
references: 19426575
references: Eur J Pharmacol. 2009 Apr 1;607(1-3):121-5
references: 19249298
references: Int J Geriatr Psychiatry. 2010 Dec;25(12):1201-8
references: 21086534
references: Arch Gerontol Geriatr. 2000 Aug 1;31(1):65-76
references: 10989165
references: Neuro Endocrinol Lett. 2002 Apr;23 Suppl 1:20-3
references: 12019347
references: Am J Geriatr Psychiatry. 2004 Jul-Aug;12(4):432-6
references: 15249281
references: J Psychopharmacol. 2010 Nov;24(11):1577-601
references: 20813762
references: Recent Pat Endocr Metab Immune Drug Discov. 2011 May;5(2):80-90
references: 22074583
references: J Pineal Res. 2001 Jan;30(1):34-42
references: 11168905
references: J Pineal Res. 2010 Sep;49(2):123-9
references: 20536684
references: J Clin Psychopharmacol. 2004 Aug;24(4):456-9
references: 15232344
references: Clin Geriatr Med. 2010 Nov;26(4):583-605
references: 20934612
references: Curr Neuropharmacol. 2010 Sep;8(3):218-27
references: 21358972
references: J Aging Res. 2011;2011:383091
references: 22028968
references: Neuroendocrinology. 1984 Oct;39(4):307-13
references: 6493445
references: Neuro Endocrinol Lett. 2000;21(1):39-42
references: 11455329